Ci Investments Inc. Invitae Corp Transaction History

Ci Investments Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.2 - $2.73 $342 - $778	-285 Reduced 1.27%	22,101 $30,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $32,106 - $67,781	18,776 Added 520.11%	22,386 $42,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $511 - $2,321	-269 Reduced 6.93%	3,610 $9,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $6,115 - $25,867	2,871 Added 284.82%	3,879 $9,000
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $6,261 - $15,543	997 Added 9063.64%	1,008 $8,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $267 - $369	11 New	11 $0
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $358,006 - $616,494	-10,829 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $423,305 - $621,584	10,829 New	10,829 $453,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.